Applicant, as named in the Orange Book

Inforlife

Next listed expiry: Midazolam In 0.9% Sodium Chloride on 20 Jun 2038. 2 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Midazolam In 0.9% Sodium Chloride · 2 strengths midazolam	midazolam	211844	20 Jun 2038	patent
Norepinephrine Bitartrate In 0.9% Sodium Chloride · 4 strengths norepinephrine bitartrate	norepinephrine bitartrate	215700	26 Apr 2039	patent

Products without listed protection (1)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Zoledronic Acid zoledronic acid	zoledronic acid	203231	open now	no listed protection